CNST Constellation Pharmaceuticals, Inc. Stock Quote

CNST [NASD]

Index	-	P/E	-	EPS (ttm)	-3.03	Insider Own	1.53%	Shs Outstand	47.84M	Perf Week	0.00%
Market Cap	1.61B	Forward P/E	-	EPS next Y	-3.95	Insider Trans	-7.45%	Shs Float	47.18M	Perf Month	75.52%
Income	-141.00M	PEG	-	EPS next Q	-0.88	Inst Own	-	Short Float	16.12%	Perf Quarter	9.95%
Sales	-	P/S	-	EPS this Y	-37.30%	Inst Trans	2.40%	Short Ratio	5.93	Perf Half Y	15.13%
Book/sh	7.89	P/B	4.27	EPS next Y	-10.60%	ROA	-29.90%	Target Price	41.88	Perf Year	-2.32%
Cash/sh	8.00	P/C	4.21	EPS next 5Y	-	ROE	-33.10%	52W Range	17.00 - 40.84	Perf YTD	17.01%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-17.38%	Beta	-
Dividend %	-	Quick Ratio	15.40	Sales past 5Y	-	Gross Margin	-	52W Low	98.47%	ATR	1.15
Employees	154	Current Ratio	15.40	Sales Q/Q	-	Oper. Margin	-	RSI (14)	82.75	Volatility	0.46% 2.86%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-37.50%	Profit Margin	-	Rel Volume	0.62	Prev Close	33.70
Shortable	Yes	LT Debt/Eq	0.00	Earnings	May 10 BMO	Payout	-	Avg Volume	1.28M	Price	33.74
Recom	2.70	SMA20	28.62%	SMA50	43.36%	SMA200	30.67%	Volume	677,728	Change	0.12%

Jun-04-21

Downgrade

Jefferies

Buy → Hold

$33 → $34

Jun-03-21

Downgrade

Cowen

Outperform → Market Perform

Jan-25-21

Upgrade

BMO Capital Markets

Market Perform → Outperform

$50

Sep-08-20

Downgrade

Oppenheimer

Outperform → Perform

Jul-20-20

Resumed

Jefferies

Buy

Jun-24-20

Initiated

JMP Securities

Mkt Perform

$36

May-07-20

Reiterated

H.C. Wainwright

Buy

$50 → $75

Feb-13-20

Initiated

SunTrust

Buy

$50

Feb-07-20

Initiated

Cowen

Outperform

Jan-09-20

Downgrade

BMO Capital Markets

Outperform → Market Perform

$43 → $42

Sep-04-19

Initiated

RBC Capital Mkts

Outperform

$20

Jan-29-19

Initiated

Robert W. Baird

Outperform

$17

Dec-20-18

Initiated

H.C. Wainwright

Buy

$18

Dec-20-18

Initiated

H.C. Wainwright

Buy

Aug-13-18

Initiated

JP Morgan

Overweight

$17

Jun-15-21 09:30AM	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates MMAC, ONB, CNST, SLCT; Shareholders are Encouraged to Contact the Firm PR Newswire
Jun-11-21 08:15PM	Lifshitz Law Firm, P.C. Announces Investigation of CNST, EQT, FFWM, TGRF, MDP, MMAC, QTS, SLCT, FBNC, USCR PR Newswire
09:00AM	Constellation Pharmaceuticals Provides an Update from the Ongoing MANIFEST Study of Pelabresib GlobeNewswire
Jun-10-21 11:25PM	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates DSSI, FMBI, CNST, SLCT; Shareholders are Encouraged to Contact the Firm ACCESSWIRE
Jun-09-21 01:04PM	SHAREHOLDER ALERT: WeissLaw LLP Reminds COHR, FMBI, SLCT, and CNST Shareholders About Its Ongoing Investigations GlobeNewswire
Jun-08-21 03:09PM	Moore Kuehn Encourages USCR, QTS, CNST and ESXB Investors to Contact Law Firm PR Newswire
11:13AM	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CLDR, FMBI, CNST, SLCT; Shareholders are Encouraged to Contact the Firm GlobeNewswire
Jun-07-21 06:02PM	Lifshitz Law Firm, P.C. Announces Investigation of CNST, FFWM, ONB, and QTS ACCESSWIRE
Jun-05-21 06:12PM	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CNST, FMBI, SWN, ENVB, MLND; Shareholders are Encouraged to Contact the Firm PR Newswire
Jun-04-21 11:47PM	SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Constellation Pharmaceuticals, Inc. - CNST PR Newswire
08:00PM	Lifshitz Law Firm, P.C. Announces Investigation of ESXB, UBSI, CNST, MOR, EQT, FFWM, TGRF, MDP, MMAC, SLCT, FBNC, and SWN PR Newswire
09:00AM	Constellation Pharmaceuticals Presents Phase 1 Data for CPI-0209 at ASCO Annual Meeting GlobeNewswire
Jun-03-21 07:07PM	Why MorphoSys Stock Sank This Week Motley Fool
06:50PM	Why Constellation Pharmaceuticals Stock Was Crushing It This Week Motley Fool
02:27PM	CONSTELLATION ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of CNST and Encourages Investors to Contact the Firm GlobeNewswire
01:16PM	Constellation (CNST) Surges on Takeover Deal With MorphoSys Zacks
Jun-02-21 06:03PM	SHAREHOLDER ALERT: WeissLaw LLP Investigates Constellation Pharmaceuticals, Inc. PR Newswire +65.86%
04:08PM	Constellation Pharma Rockets On Word Of $1.7 Billion MorphoSys Takeover Investor's Business Daily
12:16PM	Why Constellation Pharmaceuticals Stock Is Skyrocketing Today Motley Fool
10:58AM	Shareholder Alert: Ademi LLP investigates whether Constellation Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with MorphoSys PR Newswire
10:50AM	SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Constellation Pharmaceuticals, Inc. Buyout GlobeNewswire
10:50AM	MorphoSys Buys Constellation Pharma in $1.7B Deal. Is Biotech M&A Back? Barrons.com
10:17AM	UPDATE 1-Morphosys to acquire Constellation Pharma in $1.7 bln deal Reuters
10:14AM	Constellation Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Constellation Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm CNST Business Wire
09:54AM	Constellation Pharma Rockets On Word Of $1.7 Billion MorphoSys Takeover Investor's Business Daily
09:10AM	MorphoSys to Acquire Constellation Pharma at $34/Share; Enters $2B Strategic Funding with Royalty Pharma Benzinga
09:05AM	(CNST Alert) Johnson Fistel Investigates Proposed Sale of Constellation Pharmaceuticals; Are Shareholders Getting a Fair Deal? PR Newswire
07:53AM	MorphoSys to buy Constellation Pharma for $1.7 billion; Constellation's stock soars 61% MarketWatch
07:40AM	Royalty Pharma Announces $2.025 Billion Strategic Funding Partnership With MorphoSys GlobeNewswire
07:25AM	MorphoSys to Acquire Constellation Pharmaceuticals Business Wire
May-31-21 09:00AM	Constellation Pharmaceuticals to Participate in Jefferies Virtual Healthcare Conference GlobeNewswire
May-10-21 05:30PM	Constellation Pharmaceuticals (CNST) Q1 2021 Earnings Call Transcript Motley Fool
07:00AM	Constellation Pharmaceuticals Announces First-Quarter 2021 Financial Results and Provides Business Update GlobeNewswire
06:15AM	Constellation Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Apr-27-21 11:30AM	Constellation Pharmaceuticals to Host Conference Call to Discuss First Quarter 2021 Results GlobeNewswire
Apr-08-21 11:10AM	Is CNST Stock A Buy or Sell? Insider Monkey
Feb-26-21 12:40AM	Here's Why We're Not Too Worried About Constellation Pharmaceuticals' (NASDAQ:CNST) Cash Burn Situation Simply Wall St. -5.65%
Feb-24-21 10:30PM	Constellation Pharmaceuticals (CNST) Q4 2020 Earnings Call Transcript Motley Fool -25.03%
07:00AM	Constellation Pharmaceuticals Announces Fourth-Quarter and Full-Year 2020 Financial Results GlobeNewswire
06:15AM	Constellation Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Feb-19-21 04:00PM	Constellation Pharmaceuticals to Participate in the 10th Annual SVB Leerink Global Healthcare Conference GlobeNewswire
Feb-18-21 10:00AM	Constellation Pharmaceuticals to Host Conference Call to Discuss Fourth Quarter 2020 Results GlobeNewswire
Feb-16-21 01:27PM	15 Best Micro-Cap Stocks to Buy Now Insider Monkey
Jan-25-21 12:32PM	Pharma Stock Ideas: Why BMO Is Recommending Regeneron, Constellation Benzinga
Jan-07-21 09:30AM	Constellation Pharmaceuticals Appoints Brendan Delaney as Chief Commercial Officer GlobeNewswire +5.26%
Jan-06-21 10:00AM	Constellation Pharmaceuticals to Present at J.P. Morgan Healthcare Conference GlobeNewswire
Dec-07-20 04:20PM	Here Are The Winners Of This Year's Biggest Blood Cancer Meeting Investor's Business Daily +34.10%
Dec-06-20 08:00AM	Constellation Pharmaceuticals Provides Update of MANIFEST Study for CPI-0610 at ASH Meeting GlobeNewswire
Nov-23-20 01:00PM	Constellation Pharmaceuticals to Host Analyst / Investor Event to Discuss Update of MANIFEST Clinical Trial for CPI-0610 Presented at ASH Meeting GlobeNewswire
Nov-10-20 10:22AM	Was The Smart Money Wrong About Constellation Pharmaceuticals, Inc. (CNST)? Insider Monkey
Oct-29-20 07:00AM	Constellation Pharmaceuticals Announces Third-Quarter 2020 Financial Results GlobeNewswire -19.94%
06:00AM	Constellation Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Oct-19-20 02:00PM	Constellation Pharmaceuticals to Host Conference Call to Discuss Third Quarter 2020 Results GlobeNewswire
Sep-10-20 10:06AM	Hedge Funds Are Betting On Constellation Pharmaceuticals, Inc. (CNST) Insider Monkey
Sep-09-20 03:00PM	Constellation Pharmaceuticals to Participate in Upcoming Virtual Investor Conferences GlobeNewswire
Sep-03-20 10:21AM	Benzinga's Top Upgrades, Downgrades For September 3, 2020 Benzinga
Aug-05-20 07:00AM	Constellation Pharmaceuticals Announces Second-Quarter 2020 Financial Results, Provides Regulatory Update GlobeNewswire -7.39%
Aug-04-20 11:08AM	Why Constellation Pharmaceuticals (CNST) Might Surprise This Earnings Season? Zacks
Jul-31-20 12:00PM	Constellation Pharmaceuticals to Host Conference Call to Discuss Second Quarter 2020 Results GlobeNewswire
Jul-20-20 12:15PM	Did Hedge Funds Make The Right Call On Constellation Pharmaceuticals, Inc. (CNST) ? Insider Monkey
Jul-15-20 01:15PM	Steven Cohen Homes in on Otonomy GuruFocus.com
Jul-06-20 12:13PM	What Type Of Shareholders Make Up Constellation Pharmaceuticals, Inc.'s (NASDAQ:CNST) Share Registry? Simply Wall St.
Jun-22-20 04:35PM	Repare and Forma Shares Gobbled Up in IPO GuruFocus.com +6.57%
Jun-16-20 08:27PM	Constellation Pharmaceuticals Announces Pricing of Public Offering of Common Stock GlobeNewswire
Jun-15-20 04:01PM	Constellation Pharmaceuticals Announces Proposed Public Offering of Common Stock GlobeNewswire +9.33%
09:47AM	Is Constellation Pharmaceuticals, Inc. (CNST) A Good Stock To Buy? Insider Monkey
Jun-12-20 02:30AM	Constellation Pharmaceuticals Provides Updates of MANIFEST Study for CPI-0610 and EZH2 Franchise GlobeNewswire
Jun-10-20 11:30AM	Constellation Pharmaceuticals to Participate in Investor Conference GlobeNewswire
Jun-08-20 08:00AM	Constellation Pharmaceuticals Announces Appointment of Dr. Jeffrey Humphrey as Chief Medical Officer GlobeNewswire
May-29-20 09:00AM	Constellation Pharmaceuticals to Participate in Investor Conference GlobeNewswire +5.74%
May-28-20 12:00PM	Constellation Pharmaceuticals to Host Analyst / Investor Event to Discuss Update of MANIFEST Clinical Trial for CPI-0610 GlobeNewswire
May-25-20 12:00PM	Constellation Pharmaceuticals, Inc. (CNST) Upgraded to Buy: What Does It Mean for the Stock? Zacks
May-14-20 09:24AM	Is Constellation (CNST) Stock a Solid Choice Right Now? Zacks -5.37%
08:00AM	Constellation Pharmaceuticals Provides Update of Preliminary Data for CPI-0610 in Three EHA Abstracts GlobeNewswire
May-09-20 08:22PM	Was The Smart Money Right About Constellation Pharmaceuticals (CNST)? Insider Monkey
May-06-20 03:32PM	Constellation Pharmaceuticals (CNST) Q1 2020 Earnings Call Transcript Motley Fool +12.33%
07:00AM	Constellation Pharmaceuticals Announces First-Quarter 2020 Financial Results GlobeNewswire
May-05-20 02:06PM	Constellation Pharmaceuticals to Participate in Two Investor Conferences GlobeNewswire +5.07%
Apr-28-20 09:00AM	Constellation Pharmaceuticals to Host Conference Call to Discuss First Quarter 2020 Results GlobeNewswire
Apr-24-20 12:00PM	What Makes Constellation Pharmaceuticals, Inc. (CNST) a New Buy Stock Zacks +8.52%
Apr-06-20 07:00AM	Constellation Pharmaceuticals Announces Appointment of Dr. Richard Levy to Board of Directors GlobeNewswire
Mar-24-20 08:58AM	Why You Shouldn't Bet Against Constellation Pharmaceuticals (CNST) Stock Zacks +7.32%
Mar-16-20 12:00PM	What Makes Constellation Pharmaceuticals, Inc. (CNST) a New Buy Stock Zacks -19.61%
Mar-10-20 04:12PM	Constellation Pharmaceuticals Announces Fourth-Quarter and Full-Year 2019 Financial Results GlobeNewswire
03:00PM	Constellation Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Mar-06-20 01:00PM	Constellation Pharmaceuticals to Host Conference Call to Discuss Fourth Quarter 2019 Results GlobeNewswire
Feb-26-20 09:00AM	Constellation Pharmaceuticals to Present at Investor Conferences GlobeNewswire -5.20%
Feb-19-20 10:35AM	Revolution Medicines Joins Amgen and Mirati in Quest for New Type of Cancer Drugs GuruFocus.com
Jan-09-20 02:50PM	Top Biotech Stocks for Q1 2020 Investopedia -6.93%
Jan-06-20 12:34PM	Constellation Pharmaceuticals to Present at J.P. Morgan Healthcare Conference GlobeNewswire -8.22%
Dec-27-19 02:19PM	Biotech Rally Sends Nasdaq to 9000: ETFs in Focus Zacks -5.07%
Dec-16-19 06:00AM	Hedge Funds Have Never Been More Bullish On Constellation Pharmaceuticals, Inc. (CNST) Insider Monkey +14.50%
Dec-13-19 04:05PM	Constellation Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares GlobeNewswire
Dec-10-19 09:05PM	Constellation Pharmaceuticals Announces Pricing of Public Offering of Common Stock GlobeNewswire
Dec-09-19 04:18PM	Constellation Pharmaceuticals Announces Proposed Public Offering of Common Stock GlobeNewswire -17.30%
10:00AM	Constellation Pharmaceuticals Provides Updated Preliminary Data from MANIFEST Clinical Trial with CPI-0610 in Oral and Poster Presentations at ASH GlobeNewswire
Dec-02-19 11:00AM	Constellation Pharmaceuticals to Host Analyst/Investor Meeting at ASH to Discuss Updated Preliminary Data from the MANIFEST Clinical Trial with CPI-0610 GlobeNewswire
Nov-29-19 12:15PM	Biotech Tops in November: Best ETFs & Stocks Zacks +8.99%
Nov-25-19 12:43PM	Top Small Cap Stocks for December 2019 Investopedia
Nov-13-19 09:00AM	Constellation Pharmaceuticals to Participate in Upcoming Investor Conferences GlobeNewswire +5.23%

Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics to address serious unmet medical needs in patients with cancers associated with abnormal gene expression or drug resistance. The company's lead product candidates include Pelabresib that is in Phase 3 clinical trials for the treatment of patients with myelofibrosis in combination with ruxolitinib. It is also developing CPI-0209 that is in Phase 1 dose escalation portion of a Phase 1/2 clinical trial to treat solid tumors; and CPI-482, which is in preclinical stage for cancer patients. The company was formerly known as Epigenetix, Inc. and changed its name to Constellation Pharmaceuticals, Inc. in March 2008. Constellation Pharmaceuticals, Inc. was incorporated in 2008 and is headquartered in Cambridge, Massachusetts.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
GOLDSMITH MARK A	Director	Mar 04	Option Exercise	0.00	14,987	0	14,987	Mar 08 05:44 PM
Reeve Emma	Chief Financial Officer	Feb 22	Option Exercise	8.04	6,260	50,330	6,260	Feb 23 05:58 PM
Reeve Emma	Chief Financial Officer	Feb 22	Sale	37.60	6,260	235,373	0	Feb 23 05:58 PM
Reeve Emma	Chief Financial Officer	Feb 19	Option Exercise	8.04	4,010	32,240	4,010	Feb 23 05:58 PM
Reeve Emma	Chief Financial Officer	Feb 19	Sale	37.71	4,010	151,218	0	Feb 23 05:58 PM
Reeve Emma	Chief Financial Officer	Feb 18	Option Exercise	8.04	1,100	8,844	1,100	Feb 19 04:17 PM
Reeve Emma	Chief Financial Officer	Feb 18	Sale	37.58	1,100	41,343	0	Feb 19 04:17 PM
Reeve Emma	Chief Financial Officer	Feb 17	Option Exercise	8.04	410	3,296	410	Feb 19 04:17 PM
COLUMN GROUP L P	10% Owner	Feb 17	Sale	36.95	10,000	369,503	99,155	Feb 19 05:31 PM
COLUMN GROUP L P	10% Owner	Feb 17	Sale	36.95	10,000	369,503	99,155	Feb 19 05:32 PM
Reeve Emma	Chief Financial Officer	Feb 17	Sale	37.56	410	15,398	0	Feb 19 04:17 PM
Valentine Karen	See Remarks	Jan 19	Option Exercise	11.50	17,203	197,834	17,203	Jan 20 05:56 PM
Valentine Karen	See Remarks	Jan 19	Sale	33.97	17,203	584,463	0	Jan 20 05:56 PM
Reeve Emma	Chief Financial Officer	Dec 21	Option Exercise	6.81	5,720	38,975	5,720	Dec 22 04:53 PM
Reeve Emma	Chief Financial Officer	Dec 21	Sale	35.11	5,720	200,805	0	Dec 22 04:53 PM
GOLDSMITH MARK A	Director	Dec 21	Sale	35.02	4,020	140,769	139,043	Dec 28 04:02 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience